Moderna, Inc. (BMV:MRNA)

Moderna Statistics

Total Valuation

Moderna has a market cap or net worth of MXN 202.67 billion. The enterprise value is 75.20 billion.

Market Cap	202.67B
Enterprise Value	75.20B

Important Dates

The last earnings date was Thursday, July 31, 2025.

Earnings Date	Jul 31, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	389.08M
Shares Outstanding	n/a
Shares Change (YoY)	+1.05%
Shares Change (QoQ)	+0.52%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	363.31M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.49
PB Ratio	1.14
P/TBV Ratio	1.16
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-1.37
EV / Sales	1.30
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.14

Financial Position

The company has a current ratio of 3.93, with a Debt / Equity ratio of 0.08.

Current Ratio	3.93
Quick Ratio	3.55
Debt / Equity	0.08
Debt / EBITDA	n/a
Debt / FCF	-0.21
Interest Coverage	-233.79

Financial Efficiency

Return on equity (ROE) is -27.50% and return on invested capital (ROIC) is -17.69%.

Return on Equity (ROE)	-27.50%
Return on Assets (ROA)	-14.78%
Return on Invested Capital (ROIC)	-17.69%
Return on Capital Employed (ROCE)	-31.36%
Revenue Per Employee	10.01M
Profits Per Employee	-9.44M
Employee Count	5,800
Asset Turnover	0.22
Inventory Turnover	16.52

Taxes

Income Tax	-792.04M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -68.25% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-68.25%
50-Day Moving Average	552.69
200-Day Moving Average	693.90
Relative Strength Index (RSI)	38.79
Average Volume (20 Days)	1,095

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	6.07

Income Statement

In the last 12 months, Moderna had revenue of MXN 58.05 billion and -54.75 billion in losses. Loss per share was -141.95.

Revenue	58.05B
Gross Profit	-41.47B
Operating Income	-61.72B
Pretax Income	-55.54B
Net Income	-54.75B
EBITDA	-57.80B
EBIT	-61.72B
Loss Per Share	-141.95

Balance Sheet

The company has 96.76 billion in cash and 13.97 billion in debt, giving a net cash position of 127.56 billion.

Cash & Cash Equivalents	96.76B
Total Debt	13.97B
Net Cash	127.56B
Net Cash Per Share	n/a
Equity (Book Value)	177.25B
Book Value Per Share	455.65
Working Capital	86.73B

Cash Flow

In the last 12 months, operating cash flow was -50.86 billion and capital expenditures -14.95 billion, giving a free cash flow of -65.82 billion.

Operating Cash Flow	-50.86B
Capital Expenditures	-14.95B
Free Cash Flow	-65.82B
FCF Per Share	n/a

Margins

Gross margin is -71.44%, with operating and profit margins of -106.34% and -94.31%.

Gross Margin	-71.44%
Operating Margin	-106.34%
Pretax Margin	-95.68%
Profit Margin	-94.31%
EBITDA Margin	-99.58%
EBIT Margin	-106.34%
FCF Margin	n/a

Dividends & Yields

Moderna does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.05%
Shareholder Yield	n/a
Earnings Yield	-27.01%
FCF Yield	-32.47%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Moderna has an Altman Z-Score of 5.27 and a Piotroski F-Score of 1.

Altman Z-Score	5.27
Piotroski F-Score	1